23 May 2013
Keywords: sanofi, taxotere, gets, priority, review, advanced, gastric
Article | 12 December 2005
Sanofi-Aventis says that the US Food and Drug Administration has granted a six-month priority review for the supplemental New Drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 December 2005
22 May 2013
© 2013 thepharmaletter.com